PORTFOLIO            
About Us
Red Abbey Team
Contact Us

 

Portfolio


Red Abbey Venture Partners is creating a portfolio of investments that is diversified by geography, by stage of development, by sector and by therapeutic indication. We are seeking to invest in high quality life sciences companies based in North America and Europe. We have invested in both early and late stage companies, as well as PIPE transactions. We invest in product-focused biotechnology, specialty pharmaceuticals, game changing platform technologies, medical devices, diagnostics, drug delivery, tools and other life sciences companies.

 

Advanced Biohealing, Inc. La Jolla, CA
Specialty biotechnology company focused on the development and marketing of cell-based and tissue-engineered products. www.advancedbiohealing.com

logo

Aegerion Pharmaceuticals, Inc. Bridgewaer, NJ
Specialty pharmaceutical company focusing on the development and commercialization of promising therapeutics to treat cardiovascular / metabolic disease. www.aegerion.com

Alba Therapeutics Corporation Baltimore, MD
Biopharmaceutical company focused on the discovery, development and commercialization of therapeutics to treat autoimmune, immune mediated and inflammatory diseases. www.albatherapeutics.com
Anacor Pharmaceuticals, Inc. Palo Alto, CA
Biotechnology company focused on developing small-molecule, boron-based chemistry drug to develop novel product candidates for inflammatory and infectious diseases. www.anacor.com
Arginetix, Inc.   Baltimore, MD
Biopharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase.  www.arginetix.com
CoGenesys, Inc. Rockville, MD
Biopharmaceutical company focused on developing innovative long-acting medicines across broad therapeutic areas. www.cogenesys.com
Concentric Medical, Inc. Mountain View, CA
Medical device company that designs, develops and markets products for restoring blood flow in patients who have suffered ischemic strokes, which result from blood clots in the vessels of the brain. www.concentric-medical.com
Cyclacel Pharmaceuticals, Inc. Berkeley Heights, NJ
Biopharmaceutical company focused on developing small molecule cancer therapeutics. www.cyclacel.com
Cytokinetics, Inc. South San Francisco, CA
Biopharmaceutical company focused drugs that target the cytoskeleton for the treatment of cardiovascular and oncology diseases. www.cytokinetics.com
Dynavax Technologies, Corporated Berkeley, CA
Biopharmaceutical company that discovers, develops, and commercialize innovative therapeutic products to treat and prevent infectious diseases, allergies and cancer.
www.dynavax.com
Favrille, Inc. San Diego, CA
Biopharmaceutical company focused on the development and commercialization of patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system.
Inhibitex, Inc. Alpharetta, GA
Biopharmaceutical company focused on the development of products that can treat, prevent or diagnose serious infections. www.inhibitex.com
Insulet Corporation Bedford, MA
Medical company that develops, manufactures, and commercializes a novel insulin pump. www.myomnipod.com
Iomai Corporation Gaithersburg, MD
Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization. www.iomai.com
Kanisa Pharmaceuticals San Diego, CA
Biopharmaceutical company employing a targeted approach to the diagnosis and treatment of cancer. www.kanisapharm.com
Kémia, Inc. San Diego, CA
Biopharmaceutical company that discovers and develops novel small molecule therapeutics targeting validated high value disease targets not yet addressed by safe and effective orally active drugs.
MacroGenics, Inc. Rockville, MD
Biopharmaceutical company developing monoclonal antibodies to treat patients with cancer, autoimmune disorders, allergy, or infectious diseases and vaccines to prevent infections in healthy individuals. www.macrogenics.com
Metabasis Therapeutics, Inc. La Jolla, CA
Biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapies drugs for diseases of the liver.
www.mbasis.com
Nereus Pharmaceuticals San Diego, CA
Biopharmaceutical company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. www.nereuspharm.com
NicOx, SA France
Biopharmaceutical company dedicated to the development of nitric oxide-donating drugs to meet unmet medical needs. www.nicox.com
Oxagen Limited Oxfordshire, United Kingdom
Biopharmaceutical company focused on developing novel small molecule drugs for inflammatory diseases. www.oxagen.co.uk
Santarus, Inc. San Diego, CA
Specialty pharmaceutical company focused on acquiring, developing and commercializing products for the prevention and treatment of gastrointestinal diseases and disorders. www.santarus.com
Sirtris Pharmaceuticals, Inc. Cambridge, MA
Biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. www.sirtrispharma.com
Stromedix Cambridge, MA
Biotechnology company focused on developing drugs to treat fibrotic organ failure.
www.stromedix.com
   

         
Copyright © 2004 - 2008  •  RED ABBEY VENTURE PARTNERS  •  All Rights Reserved

 

Red Abbey Venture Partners